---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-25-000005"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:04:16.816737+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics reports record FY2024 revenue of $204.7M (+38% YoY), issues 2025 guidance

## Summary
- Preliminary unaudited FY2024 revenue $204.7M, up 38% from $148.7M in 2023.
- Q4 2024 revenue $52.7M (+40% YoY); domestic Q4 $42.9M (+52%), international $9.8M (+5%).
- 2025 revenue guidance $235-242M (15-18% growth); adjusted EBITDA $15-17M.
- Over 34,000 children helped in Q4; cumulative >1.1 million since inception.
- Annual set deployment ~$15M in 2025; full results due in early March.

## SEC filing metadata
- accession: 0001425450-25-000005
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000005/0001425450-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000005/kids-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-25-000005
- JSON: https://secwatch.observer/filing/0001425450-25-000005.json
- Plain text: https://secwatch.observer/filing/0001425450-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.